Copyright Reports & Markets. All rights reserved.

Global Hematopoietic Progenitor Cells Transplantation Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Hematopoietic Progenitor Cells Transplantation Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Hematopoietic Progenitor Cell Storage
    • 1.2.3 Hematopoietic Progenitor Cells Consumables
  • 1.3 Market by Application
    • 1.3.1 Global Hematopoietic Progenitor Cells Transplantation Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Leukemia
    • 1.3.3 Lymphoproliferative Disorders
    • 1.3.4 Solid Tumors
    • 1.3.5 Non-Malignant Disorders
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Hematopoietic Progenitor Cells Transplantation Market Perspective (2016-2027)
  • 2.2 Hematopoietic Progenitor Cells Transplantation Growth Trends by Regions
    • 2.2.1 Hematopoietic Progenitor Cells Transplantation Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Hematopoietic Progenitor Cells Transplantation Historic Market Share by Regions (2016-2021)
    • 2.2.3 Hematopoietic Progenitor Cells Transplantation Forecasted Market Size by Regions (2022-2027)
  • 2.3 Hematopoietic Progenitor Cells Transplantation Industry Dynamic
    • 2.3.1 Hematopoietic Progenitor Cells Transplantation Market Trends
    • 2.3.2 Hematopoietic Progenitor Cells Transplantation Market Drivers
    • 2.3.3 Hematopoietic Progenitor Cells Transplantation Market Challenges
    • 2.3.4 Hematopoietic Progenitor Cells Transplantation Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Hematopoietic Progenitor Cells Transplantation Players by Revenue
    • 3.1.1 Global Top Hematopoietic Progenitor Cells Transplantation Players by Revenue (2016-2021)
    • 3.1.2 Global Hematopoietic Progenitor Cells Transplantation Revenue Market Share by Players (2016-2021)
  • 3.2 Global Hematopoietic Progenitor Cells Transplantation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Hematopoietic Progenitor Cells Transplantation Revenue
  • 3.4 Global Hematopoietic Progenitor Cells Transplantation Market Concentration Ratio
    • 3.4.1 Global Hematopoietic Progenitor Cells Transplantation Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Hematopoietic Progenitor Cells Transplantation Revenue in 2020
  • 3.5 Hematopoietic Progenitor Cells Transplantation Key Players Head office and Area Served
  • 3.6 Key Players Hematopoietic Progenitor Cells Transplantation Product Solution and Service
  • 3.7 Date of Enter into Hematopoietic Progenitor Cells Transplantation Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Hematopoietic Progenitor Cells Transplantation Breakdown Data by Type

  • 4.1 Global Hematopoietic Progenitor Cells Transplantation Historic Market Size by Type (2016-2021)
  • 4.2 Global Hematopoietic Progenitor Cells Transplantation Forecasted Market Size by Type (2022-2027)

5 Hematopoietic Progenitor Cells Transplantation Breakdown Data by Application

  • 5.1 Global Hematopoietic Progenitor Cells Transplantation Historic Market Size by Application (2016-2021)
  • 5.2 Global Hematopoietic Progenitor Cells Transplantation Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Hematopoietic Progenitor Cells Transplantation Market Size (2016-2027)
  • 6.2 North America Hematopoietic Progenitor Cells Transplantation Market Size by Type
    • 6.2.1 North America Hematopoietic Progenitor Cells Transplantation Market Size by Type (2016-2021)
    • 6.2.2 North America Hematopoietic Progenitor Cells Transplantation Market Size by Type (2022-2027)
    • 6.2.3 North America Hematopoietic Progenitor Cells Transplantation Market Size by Type (2016-2027)
  • 6.3 North America Hematopoietic Progenitor Cells Transplantation Market Size by Application
    • 6.3.1 North America Hematopoietic Progenitor Cells Transplantation Market Size by Application (2016-2021)
    • 6.3.2 North America Hematopoietic Progenitor Cells Transplantation Market Size by Application (2022-2027)
    • 6.3.3 North America Hematopoietic Progenitor Cells Transplantation Market Size by Application (2016-2027)
  • 6.4 North America Hematopoietic Progenitor Cells Transplantation Market Size by Country
    • 6.4.1 North America Hematopoietic Progenitor Cells Transplantation Market Size by Country (2016-2021)
    • 6.4.2 North America Hematopoietic Progenitor Cells Transplantation Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Hematopoietic Progenitor Cells Transplantation Market Size (2016-2027)
  • 7.2 Europe Hematopoietic Progenitor Cells Transplantation Market Size by Type
    • 7.2.1 Europe Hematopoietic Progenitor Cells Transplantation Market Size by Type (2016-2021)
    • 7.2.2 Europe Hematopoietic Progenitor Cells Transplantation Market Size by Type (2022-2027)
    • 7.2.3 Europe Hematopoietic Progenitor Cells Transplantation Market Size by Type (2016-2027)
  • 7.3 Europe Hematopoietic Progenitor Cells Transplantation Market Size by Application
    • 7.3.1 Europe Hematopoietic Progenitor Cells Transplantation Market Size by Application (2016-2021)
    • 7.3.2 Europe Hematopoietic Progenitor Cells Transplantation Market Size by Application (2022-2027)
    • 7.3.3 Europe Hematopoietic Progenitor Cells Transplantation Market Size by Application (2016-2027)
  • 7.4 Europe Hematopoietic Progenitor Cells Transplantation Market Size by Country
    • 7.4.1 Europe Hematopoietic Progenitor Cells Transplantation Market Size by Country (2016-2021)
    • 7.4.2 Europe Hematopoietic Progenitor Cells Transplantation Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Hematopoietic Progenitor Cells Transplantation Market Size (2016-2027)
  • 8.2 Asia-Pacific Hematopoietic Progenitor Cells Transplantation Market Size by Type
    • 8.2.1 Asia-Pacific Hematopoietic Progenitor Cells Transplantation Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Hematopoietic Progenitor Cells Transplantation Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Hematopoietic Progenitor Cells Transplantation Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Hematopoietic Progenitor Cells Transplantation Market Size by Application
    • 8.3.1 Asia-Pacific Hematopoietic Progenitor Cells Transplantation Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Hematopoietic Progenitor Cells Transplantation Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Hematopoietic Progenitor Cells Transplantation Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Hematopoietic Progenitor Cells Transplantation Market Size by Region
    • 8.4.1 Asia-Pacific Hematopoietic Progenitor Cells Transplantation Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Hematopoietic Progenitor Cells Transplantation Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Hematopoietic Progenitor Cells Transplantation Market Size (2016-2027)
  • 9.2 Latin America Hematopoietic Progenitor Cells Transplantation Market Size by Type
    • 9.2.1 Latin America Hematopoietic Progenitor Cells Transplantation Market Size by Type (2016-2021)
    • 9.2.2 Latin America Hematopoietic Progenitor Cells Transplantation Market Size by Type (2022-2027)
    • 9.2.3 Latin America Hematopoietic Progenitor Cells Transplantation Market Size by Type (2016-2027)
  • 9.3 Latin America Hematopoietic Progenitor Cells Transplantation Market Size by Application
    • 9.3.1 Latin America Hematopoietic Progenitor Cells Transplantation Market Size by Application (2016-2021)
    • 9.3.2 Latin America Hematopoietic Progenitor Cells Transplantation Market Size by Application (2022-2027)
    • 9.3.3 Latin America Hematopoietic Progenitor Cells Transplantation Market Size by Application (2016-2027)
  • 9.4 Latin America Hematopoietic Progenitor Cells Transplantation Market Size by Country
    • 9.4.1 Latin America Hematopoietic Progenitor Cells Transplantation Market Size by Country (2016-2021)
    • 9.4.2 Latin America Hematopoietic Progenitor Cells Transplantation Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Hematopoietic Progenitor Cells Transplantation Market Size (2016-2027)
  • 10.2 Middle East & Africa Hematopoietic Progenitor Cells Transplantation Market Size by Type
    • 10.2.1 Middle East & Africa Hematopoietic Progenitor Cells Transplantation Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Hematopoietic Progenitor Cells Transplantation Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Hematopoietic Progenitor Cells Transplantation Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Hematopoietic Progenitor Cells Transplantation Market Size by Application
    • 10.3.1 Middle East & Africa Hematopoietic Progenitor Cells Transplantation Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Hematopoietic Progenitor Cells Transplantation Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Hematopoietic Progenitor Cells Transplantation Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Hematopoietic Progenitor Cells Transplantation Market Size by Country
    • 10.4.1 Middle East & Africa Hematopoietic Progenitor Cells Transplantation Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Hematopoietic Progenitor Cells Transplantation Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 CBR Systems
    • 11.1.1 CBR Systems Company Details
    • 11.1.2 CBR Systems Business Overview
    • 11.1.3 CBR Systems Hematopoietic Progenitor Cells Transplantation Introduction
    • 11.1.4 CBR Systems Revenue in Hematopoietic Progenitor Cells Transplantation Business (2016-2021)
    • 11.1.5 CBR Systems Recent Development
  • 11.2 China Cord Blood Corporation
    • 11.2.1 China Cord Blood Corporation Company Details
    • 11.2.2 China Cord Blood Corporation Business Overview
    • 11.2.3 China Cord Blood Corporation Hematopoietic Progenitor Cells Transplantation Introduction
    • 11.2.4 China Cord Blood Corporation Revenue in Hematopoietic Progenitor Cells Transplantation Business (2016-2021)
    • 11.2.5 China Cord Blood Corporation Recent Development
  • 11.3 ViaCord
    • 11.3.1 ViaCord Company Details
    • 11.3.2 ViaCord Business Overview
    • 11.3.3 ViaCord Hematopoietic Progenitor Cells Transplantation Introduction
    • 11.3.4 ViaCord Revenue in Hematopoietic Progenitor Cells Transplantation Business (2016-2021)
    • 11.3.5 ViaCord Recent Development
  • 11.4 Thermo Fisher Scientific
    • 11.4.1 Thermo Fisher Scientific Company Details
    • 11.4.2 Thermo Fisher Scientific Business Overview
    • 11.4.3 Thermo Fisher Scientific Hematopoietic Progenitor Cells Transplantation Introduction
    • 11.4.4 Thermo Fisher Scientific Revenue in Hematopoietic Progenitor Cells Transplantation Business (2016-2021)
    • 11.4.5 Thermo Fisher Scientific Recent Development
  • 11.5 STEMCELL Technologies
    • 11.5.1 STEMCELL Technologies Company Details
    • 11.5.2 STEMCELL Technologies Business Overview
    • 11.5.3 STEMCELL Technologies Hematopoietic Progenitor Cells Transplantation Introduction
    • 11.5.4 STEMCELL Technologies Revenue in Hematopoietic Progenitor Cells Transplantation Business (2016-2021)
    • 11.5.5 STEMCELL Technologies Recent Development
  • 11.6 Vcanbio
    • 11.6.1 Vcanbio Company Details
    • 11.6.2 Vcanbio Business Overview
    • 11.6.3 Vcanbio Hematopoietic Progenitor Cells Transplantation Introduction
    • 11.6.4 Vcanbio Revenue in Hematopoietic Progenitor Cells Transplantation Business (2016-2021)
    • 11.6.5 Vcanbio Recent Development
  • 11.7 Merck Millipore
    • 11.7.1 Merck Millipore Company Details
    • 11.7.2 Merck Millipore Business Overview
    • 11.7.3 Merck Millipore Hematopoietic Progenitor Cells Transplantation Introduction
    • 11.7.4 Merck Millipore Revenue in Hematopoietic Progenitor Cells Transplantation Business (2016-2021)
    • 11.7.5 Merck Millipore Recent Development
  • 11.8 Lonza Group
    • 11.8.1 Lonza Group Company Details
    • 11.8.2 Lonza Group Business Overview
    • 11.8.3 Lonza Group Hematopoietic Progenitor Cells Transplantation Introduction
    • 11.8.4 Lonza Group Revenue in Hematopoietic Progenitor Cells Transplantation Business (2016-2021)
    • 11.8.5 Lonza Group Recent Development
  • 11.9 CellGenix Technologie Transfer
    • 11.9.1 CellGenix Technologie Transfer Company Details
    • 11.9.2 CellGenix Technologie Transfer Business Overview
    • 11.9.3 CellGenix Technologie Transfer Hematopoietic Progenitor Cells Transplantation Introduction
    • 11.9.4 CellGenix Technologie Transfer Revenue in Hematopoietic Progenitor Cells Transplantation Business (2016-2021)
    • 11.9.5 CellGenix Technologie Transfer Recent Development
  • 11.10 ThermoGenesis
    • 11.10.1 ThermoGenesis Company Details
    • 11.10.2 ThermoGenesis Business Overview
    • 11.10.3 ThermoGenesis Hematopoietic Progenitor Cells Transplantation Introduction
    • 11.10.4 ThermoGenesis Revenue in Hematopoietic Progenitor Cells Transplantation Business (2016-2021)
    • 11.10.5 ThermoGenesis Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Hematopoietic Progenitor Cells Transplantation Scope and Market Size
    Hematopoietic Progenitor Cells Transplantation market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hematopoietic Progenitor Cells Transplantation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Hematopoietic Progenitor Cell Storage
    Hematopoietic Progenitor Cells Consumables

    Segment by Application
    Leukemia
    Lymphoproliferative Disorders
    Solid Tumors
    Non-Malignant Disorders

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    CBR Systems
    China Cord Blood Corporation
    ViaCord
    Thermo Fisher Scientific
    STEMCELL Technologies
    Vcanbio
    Merck Millipore
    Lonza Group
    CellGenix Technologie Transfer
    ThermoGenesis

    Buy now